openPR Logo
Press release

Growing Aging Population to Fuels the Growth of the Global Cerebrovascular Disease Market| Market Opportunities and Forecast, 2018-2023 | Major Companies: Actelion Pharmaceuticals Ltd., Bayer AG, Amgen Inc., Pfizer Inc., Sanofi SA

03-12-2019 10:49 AM CET | Health & Medicine

Press release from: Orion Market Research

Orion Market Research

Orion Market Research

According to OMR analysis, the global cerebrovascular diseases treatment market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The major factors contributing to the growth of the market include increasing inherited congenital diseases and the rising aging population. Furthermore, increasing prevalence of diabetes and the increasing awareness of emerging therapies can contribute to the prominent growth of the cerebrovascular diseases treatment market in the future.

A full report of global cerebrovascular diseases treatment market is available at
https://www.omrglobal.com/industry-reports/cerebrovascular-diseases-treatment-market/

Furthermore, the global cerebrovascular diseases treatment market is segmented on the basis of type of stroke, diagnosis, treatment, end-users. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1. Global Cerebrovascular Diseases Treatment Market by Type of Stroke
• Ischemic
• Haemorrhagic

2. Global Cerebrovascular Diseases Treatment Market by Diagnosis
• Cerebral Angiography
• Carotid Duplex
• Computed Tomography
• Electroencephalogram

3. Global Cerebrovascular Diseases Treatment Market by Treatment
• Medication
o Antiplatelets
o Antihypertensives
o Others
• Surgical Procedure
o Endovascular Surgery
o Vascular Surgery
o Others

4. Global Cerebrovascular Diseases Treatment Market by End User
• Hospitals
• Surgical Clinics
• Research Institutions

Region Covered

• North America (US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)

Company Profiled

• Actelion Pharmaceuticals Ltd.
• Aldagen Inc.
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb
• Daiichi Sankyo Company, Ltd.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Johnson & Johnson Inc.
• Merck & Co., Inc.
• Novartis International AG
• Penumbra Inc
• Pfizer Inc.
• Portola Pharmaceuticals, Inc.
• Sangamo Therapeutics, Inc.
• Sanofi SA
• Sihuan Pharmaceutical Holdings Group Ltd.
• Takeda Pharmaceutical Company Ltd.
• Tianda Pharmaceuticals Ltd.
• United Therapeutics Corp.
• Zocere, Inc.

For related reports please visit https://www.omrglobal.com/reports-category/pharmaceuticals/

For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/

About Orion Market Research

Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Contact us

Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growing Aging Population to Fuels the Growth of the Global Cerebrovascular Disease Market| Market Opportunities and Forecast, 2018-2023 | Major Companies: Actelion Pharmaceuticals Ltd., Bayer AG, Amgen Inc., Pfizer Inc., Sanofi SA here

News-ID: 1648135 • Views:

More Releases from Orion Market Research

Anti-Viral Drug Market - Industry Trends and Forecast to 2033
Anti-Viral Drug Market - Industry Trends and Forecast to 2033
The global antiviral drugs market is projected to grow from USD 50 billion in 2023 to USD 71 billion by 2033, with a compound annual growth rate (CAGR) of 3.73% during the forecast period from 2024 to 2033. Anti-Viral Drug Market Overview Antiviral drugs are essential in the treatment and prevention of viral infections, including HIV, hepatitis, influenza, and emerging viral diseases. The market's growth is driven by the increasing
Tuberculosis Vaccine Market - Industry Trends and Forecast to 2032
Tuberculosis Vaccine Market - Industry Trends and Forecast to 2032
The global tuberculosis (TB) vaccine market was valued at approximately USD 63.11 billion in 2023 and is projected to reach USD 88.28 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.38% from 2024 to 2032. Tuberculosis Vaccine Market Overview The tuberculosis vaccine market is primarily driven by the Bacillus Calmette-Guérin (BCG) vaccine, which has been the standard preventive measure against TB for decades. Despite its widespread use,
Favipiravir Market: Emerging Trends and Growth Forecast to 2032
Favipiravir Market: Emerging Trends and Growth Forecast to 2032
The global Favipiravir market was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2032. Favipiravir Market Overview Favipiravir, an antiviral medication initially developed for influenza, gained prominence during the COVID-19 pandemic due to its potential efficacy against the virus. The market's growth is driven by the increasing prevalence
Beauty Tools Market Overview: Growth, Share, Value, Size, and Scope
Beauty Tools Market Overview: Growth, Share, Value, Size, and Scope
The global beauty tools market was valued at approximately USD 68.9 billion in 2023 and is projected to reach USD 99.78 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2032. Beauty Tools Market Overview The beauty tools market encompasses a wide range of products, including hair care tools, razors, trimmers, brushes, combs, and manicure and pedicure tools. The market's growth is driven by

All 5 Releases


More Releases for Treatment

Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr …
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose of
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M …
Transparency Market Research (TMR) has published a new report titled “Addiction Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smoking